WAT News & Events

BD (BDX) announced that the company's Board of Directors has set the close of business on February 5 as the record date for the previously announced spin-off of BD's Biosciences & Diagnostic Solutions business to BD's shareholders. Immediately following the spin-off, the spun-off entity will be combined with Waters Corporation (WAT) in a Reverse Morris Trust transaction. The combination is expected to be completed on February 9, subject to the satisfaction of customary closing conditions.

Waters (WAT) shareholders voted to approve the issuance of shares of Waters common stock to shareholders of Becton Dickinson (BDX) in connection with the proposed combination of BD's Biosciences & Diagnostic Solutions business with Waters. BD has received a favorable Private Letter Ruling from the IRS regarding matters relating to the U.S. federal income tax consequences of the transaction. Waters and BD have also received all of the required regulatory approvals. The transaction is expected to close on February 9, subject to the satisfaction of the remaining customary closing conditions. Preliminary results indicate that 99% of shares voted in favor of the issuance of shares of Waters common stock to BD shareholders.